On Monday, a federal judge struck down FDA’s plan to regulate lab-developed tests (LDTs) as medical devices, ruling that the agency did not have the authority to regulate such products. Advisory Board’s Rachael Peroutky details what this could mean for the future of LDT regulation. 3 questions health plan leaders are asking about labsBackgroundAccording to […]
